The Oncology segment focuses on the research and development of innovative small molecule drugs for the treatment of various cancers. This includes research into novel drug targets, the development of precursor compounds, and the execution of clinical trials to evaluate the safety and efficacy of new therapies. The company utilizes advanced technologies in drug discovery, including high-throughput screening and structure-based drug design. Patient impact is addressed by aiming to provide more effective and less toxic cancer treatments. Market positioning is based on developing first-in-class or best-in-class drugs with the potential for significant clinical benefits. Future opportunities include expanding the pipeline to cover a broader range of cancer types and developing combination therapies. Regulatory and clinical aspects involve rigorous testing and adherence to global standards for drug approval. Partnerships and collaborations are sought to accelerate drug development and commercialization.

This segment is dedicated to the development of small molecule drugs for metabolic diseases, including diabetes and related complications. Research and development efforts focus on identifying and validating drug targets, synthesizing novel compounds, and conducting preclinical and clinical studies. The company employs advanced technologies such as medicinal chemistry, pharmacology, and clinical trial management. The goal is to improve patient outcomes by providing effective treatments for metabolic disorders. Market positioning involves targeting unmet medical needs and offering innovative solutions. Future growth opportunities include expanding the product pipeline and exploring new therapeutic areas within metabolic diseases. Regulatory and clinical aspects involve navigating the drug approval process and ensuring compliance with relevant guidelines. Partnerships and collaborations are pursued to enhance research capabilities and accelerate product development.

The Autoimmune Diseases segment concentrates on the research and development of small molecule drugs to treat autoimmune disorders. This involves identifying and validating drug targets, synthesizing novel compounds, and conducting preclinical and clinical trials. The company utilizes advanced technologies in drug discovery, including high-throughput screening and structure-based drug design. The aim is to improve patient outcomes by providing effective treatments for autoimmune diseases. Market positioning is based on developing innovative therapies with the potential for significant clinical benefits. Future opportunities include expanding the pipeline to cover a broader range of autoimmune diseases and developing combination therapies. Regulatory and clinical aspects involve rigorous testing and adherence to global standards for drug approval. Partnerships and collaborations are sought to accelerate drug development and commercialization.